Sign Up to like & get recommendations! 0
Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28983
Abstract: The attention to hepatocellular carcinoma (HCC) in the United States began with observations in the late 1980s of an unexpected increase in incidence, hospitalizations, and mortality in several national registries. HCC is currently the fastest… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "European Radiology"
DOI: 10.1007/s00330-020-06904-8
Abstract: • Abbreviated MRI (AMRI) protocols consist of acquiring only a minimal number of MRI sequences for HCC surveillance with acceptable diagnostic performance compared to complete MRI. • AMRI protocol options include non-contrast AMRI, dynamic AMRI… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Annals of hepatology"
DOI: 10.1016/j.aohep.2021.100344
Abstract: INTRODUCTION AND OBJECTIVES Failures at any step in the hepatocellular carcinoma (HCC) surveillance process can result in HCC diagnostic delays and associated worse prognosis. We aimed to estimate the prevalence of surveillance failure and its… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Seminars in liver disease"
DOI: 10.1055/a-1957-8540
Abstract: The burden for hepatocellular carcinoma (HCC) attributed to nonalcoholic fatty liver disease (NAFLD) continues to grow in parallel with rising global trends in obesity. The risk of HCC is elevated among patients with NAFLD-related cirrhosis… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031907
Abstract: Hepatocellular carcinoma (HCC) surveillance can detect the early stage of tumors and lead to improved survival. Adherence to guideline-concordant HCC surveillance is crucial in at-risk populations, including patients with hepatic C virus (HCV) cirrhosis. This… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Gut"
DOI: 10.1136/gutjnl-2017-314472.182
Abstract: Introduction Hepatocellular Carcinoma (HCC) is the 17th most common cancer in the UK (new diagnoses, 2014)1. Between 2002–2004 and 2011–2013 average incidence of primary liver cancer increased significantly: 55% among males; 46% among females2. Early… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e16141
Abstract: e16141 Background: Patients with cirrhosis are advised to undergo hepatocellular carcinoma (HCC) surveillance every six months. Routine screening is associated with early tumor detection and improved survival. However, surveillance is underutilized. We aimed to characterize… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical and Molecular Hepatology"
DOI: 10.3350/cmh.2019.1001
Abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death worldwide. Prognosis and treatment options largely depend on tumor stage at diagnosis, with curative treatments only available if detected at an early… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13092251
Abstract: Simple Summary Liver cancer is a growing problem that largely impacts people with cirrhosis. This article describes the Veterans Health Administration’s national cirrhosis quality improvement program and its focus on early detection of liver cancer.… read more here.